Catecholamines regulate the b-adrenoceptor/cyclic AMP-regulated protein kinase A (cAMP/PKA) pathway. Deregulation of this pathway can cause apoptotic cell death and is implicated in a range of human diseases, such as neuronal loss during aging, cardiomyopathy and septic shock. The molecular mechanism of this process is, however, only poorly understood. Here we demonstrate that the b-adrenoceptor/cAMP/PKA pathway triggers apoptosis through the transcriptional induction of the pro-apoptotic BH3-only Bcl-2 family member Bim in tissues such as the thymus and the heart. In these cell types, the catecholamine-mediated apoptosis is abrogated by loss of Bim. Induction of Bim is driven by the transcriptional co-activator CBP (CREB-binding protein) together with the proto-oncogene c-Myc. Association of CBP with c-Myc leads to altered histone acetylation and methylation pattern at the Bim promoter site. Our findings have implications for understanding pathophysiology associated with a deregulated neuroendocrine system and for developing novel therapeutic strategies for these diseases. Cell Death and Differentiation (2013) 20, 941-952; doi:10.1038/cdd.2013 published online 12 April 2013 Cyclic adenosine monophosphate (cAMP) is a second messenger that is highly conserved throughout evolution. In metazoans, its primary role is to act as an intracellular carrier of metabolic information, regulating hormonal responses, 1 in triggering apoptotic cell death and in regulating ontogeny.
Cyclic adenosine monophosphate (cAMP) is a second messenger that is highly conserved throughout evolution. In metazoans, its primary role is to act as an intracellular carrier of metabolic information, regulating hormonal responses, 1 in triggering apoptotic cell death and in regulating ontogeny. 2, 3 Studies with transgenic mouse models have revealed that deregulation of the cyclic AMP-regulated protein kinase A (cAMP/PKA) pathway can cause apoptosis. 4 Specifically, badrenergic receptor (bAR) activation by catecholamines or autoantibodies, as seen in Grave's disease, 5 can cause PKAmediated cardiomyocyte apoptosis, resulting in heart failure (HF). 6 Furthermore, administration of catecholamines, such as epinephrine, is often the last resort for treatment of patients suffering from septic shock, 7 and this is associated with profound alterations in immune function, similar to those observed in haemorrhagic shock where all lymphocyte subsets are decreased owing to excessive apoptosis. 8 Similarly, loss of dopamine receptor containing neurons during aging has been attributed to the apoptosis-inducing effects of the catecholamine, dopamine 9 and chronic stressinduced immune modulation has been attributed to increased levels of circulating epinephrine. 10 The molecular mechanisms of cAMP/PKA pathwaymediated apoptosis are only poorly defined. The BH3-only Bcl-2 family protein Bim is considered to be an essential initiator of apoptosis in a wide variety of physiological settings, including deregulated calcium flux, growth factor withdrawal, 11 endoplasmic reticulum stress 12 and T cell receptor 13 as well as B cell receptor activation 14 in autoreactive lymphocytes. Downregulation of Bim appears to be a common denominator in many cell survival signalling pathways in cancers, and many anticancer therapeutics kill cancer cells by inducing Bim expression. 15, 16 We have previously reported that the cAMP/PKA pathway can regulate Bim protein levels by phosphorylation and stabilization. 17 However, the present work demonstrates that in many cell types and tissues, transcriptional induction of Bim by the cAMP/PKA pathway has a major role in cell death regulation.
Here we elucidate the molecular mechanism of the cAMP/ PKA-triggered apoptotic pathway downstream of bAR activation. We demonstrate that PKA activation results in the transcriptional induction of the pro-apoptotic BH3-only Bcl-2 family gene Bim and subsequent Bim-dependent apoptosis in diverse cell types, including thymocytes and cardiomyocytes. We also provide proof for the engagement of the Bim promoter by the proto-oncogene c-Myc, together with the transcriptional co-activator CREB (cAMP response element-binding protein)-binding protein (CBP). Our results shed light on the role of increased sympathetic nerve activity and apoptosis in the myocardium that can lead to HF 18 , in the development of the thymus during embryogenesis 19 and in stress-induced thymic atrophy and immune modulation. 20 Results cAMP/PKA activation induces BIM in a variety of tissues. A critical role for the pro-apoptotic BH3-only Bcl-2 family member Bim (Bcl2L11) in cAMP/PKA-triggered apoptosis has been reported in the S-49 T-cell lymphoma line. 21 To test the generality of this phenomenon, we used a variety of systems to induce PKA activity. PKA exists as a tetrameric holoenzyme composed of two catalytic (C) and two regulatory (R) subunits. Binding of cAMP causes the dissociation of the holoenzyme into its constituent subunits, that is, PKA regulatory subunit 1a (Prkar1a) and PKACa However, cAMP regulation of PKA can be bypassed by ectopic overexpression of PKACa. 22 4-hydroxytamoxifen (4-OHT)-induced expression of PKACa HA-tagged) in mouse embryonic fibroblasts (MEFs) resulted in the induction of Bim, both at the protein and mRNA levels ( Figure 1a) . Similarly, bAR stimulation by agonists, such as isoproterenol, leads to cAMP flux and PKA activation. 21 Consistent with this, treatment of MEFs with isoproterenol led to a robust induction of Bim both at the protein and mRNA levels ( Figure 1b and Supplementary Figure S1d) .
The primary and secondary lymphoid organs, such as the developing thymi as well as the spleen and lymph nodes, are innervated by the autonomic, mainly sympathetic, nervous system, allowing neuroimmune modulation. 23 Postnatal infection and stress can cause profound involution of the thymus 2 AR transgenic mouse (b 2 AR expressed under MHC promoter or MHCa) and littermate control on C57BL/6 background (at 6 months) were analyzed by echocardiogram, TUNEL staining for apoptosis or by Masson's trichrome staining for collagen accumulation. (f) LV sections were stained with Bim-specific antibodies or the antibodies pre-incubated with the peptide epitope against which the antibodies were raised to show the specificity of the staining. (g) RT-qPCR analysis of the heart tissues for Bim transcripts and (h) western blot analysis of the transgenic heart tissues with myocardial infarct (MI) as a positive control. Error bars: ± S.E.M., n ¼ 3, one-tailed T-tests. #P ¼ 0.004; *P ¼ 0.023 versus untreated control (b); #P ¼ 0.002-0.0012 versus untreated control (c); #P ¼ 0.0014 versus untreated control (d); #P ¼ 0.013 versus wild-type (WT) control gland, and this is attributed to increased secretion of catecholamines by the sympathetic nervous system. 24 As Bim is critical for the killing of thymocytes by diverse apoptotic stimuli, 11 we tested whether thymocytes could upregulate Bim in response to catecholamines. Treatment of thymocytes in foetal thymic organ culture (FTOC) with isoproterenol resulted in a robust induction of Nur77, a marker for PKA activation 25 and Bim, whereas the expression of other BH3-only genes, such as Puma (Bbc3) and Noxa remained unchanged (Figure 1c) .
b-adrenergic stimulation leads to PKA-mediated apoptosis in adult cardiomyocytes. 26 Accordingly, isoproterenol treatment induced Nur77 and Bim expression in cardiomyocytes isolated from adult mice by Langendorff perfusion (Figure 1d) . Similar results were obtained in in vivo mouse models. Similar to what was seen in b 1 AR transgenic animals, 27 cardiomyocyte-specific transgenic overexpression of b 2 AR led to cardiomyocyte apoptosis, hypertrophy and ultimately HF. 28 These transgenic mice had enlarged hearts, dilated left ventricles (LV) and increased fibrosis, as revealed by echocardiogram, TUNEL and collagen staining ( Figure 1e and Supplementary Figure S1a) . Immunohistochemical staining of heart sections demonstrated that hearts in these transgenic mice expressed higher levels of Bim compared with hearts from wild-type (WT) mice (Figure 1f ). Quantitative PCR (qPCR) and western blot analyses of these heart tissues indicated that Bim was induced in these mice both at the mRNA and protein levels (Figures 1g and h ). The heart is richly innervated by sympathetic nerves, which regulate cardiac function by the release of catecholamines that act on bARs. Excessive catecholamine levels are correlated with failing myocardium. 29 Consistent with this notion, induction of myocardial infarction by left coronary artery ligation resulted in increased levels of both adrenaline and nor-adrenaline in the serum of C57BL/6 mice, and this was accompanied by increased Bim protein expression ( Supplementary Figures S1b and c) . Similar to what we observed in thymocytes, this induction was specific to Bim, as we did not detect any induction of other BH3-only proteins, such as Puma (Supplementary Figure S1c) .
Loss of Bim inhibits cAMP/PKA-induced apoptosis. Consistent with the reports from T hybridoma cells, 21 our results show that Bim is a downstream target of the cAMP/ PKA pathway in diverse tissues. We therefore examined whether Bim was required for PKA-induced apoptosis. Apart from the sympathetic nervous system, immune cells themselves can synthesize and metabolize catecholamines and stimulate bARs. Immune cells are therefore considered to be 'a new, diffusely distributed adrenergic organ'. 4 Catecholamines regulate lymphocyte proliferation, differentiation and apoptosis via an autocrine loop. 30 Therefore, we tested whether loss of Bim could protect thymocytes from bAR-mediated apoptosis in FTOC. Treatment of FTOC with isoproterenol resulted in Bim protein induction (Supplementary Figure S2a) Figure S2a , lanes 2 and 4 and Figure 2c ). (Constitutive levels of both pCREB and cAMP levels were higher in Bim À / À cells; this might be because of the survival of thymocytes with high cAMP/PKA activity in the absence of Bim.)
In an acute mouse model of HF, injection of isoproterenol (15 mg/kg per day for 7 days) causes ventricular remodelling, leading to cardiac hypertrophy. 31 Although isoproterenol injection resulted in impaired contractile function of the LV (significantly lower fractional shortening and lower fractional area change) in the WT mice, the Bim À / À mice did not develop this pathology (Figures 2d-f) . Accordingly, many more TUNEL þ (apoptotic) cells were seen in WT mice compared with the Bim À / À animals (Supplementary Figure S2b) . Similarly, whereas cardiomyocytes isolated from adult WT mice by Langendorff perfusion underwent substantial apoptosis after treatment with isoproterenol, those from Bim À / À mice were resistant (Supplementary Figure S2c) . Apart from rescuing the catecholamine-induced pathology, Bim ablation also resulted in constitutive physiological hypertrophy of the heart. This is characterized by increased weight of LV and whole heart, and this could be attributed to increased size of cardiomyocytes (Figures 3a and b and Supplementary Figure S2d) . Furthermore, gene expression analysis of WT and Bim À / À heart tissues indicated that the cardiac hypertrophy is not associated with any pathology, as we did not observe any of the pathological hypertrophyassociated gene induction in the Bim À / À hearts ( Figure 3c ).
Prkar1a deletion induces apoptosis and this can be inhibited by loss of Bim. The discovery that the exchange protein activated by cAMP (Epac) is a direct target of cAMP with an affinity comparable to the regulatory subunit of PKA 32 questions the long-held notion that PKA is the only direct downstream target of cAMP. To rule out that Epac is critical for the induction of Bim, we used a genetic model in which PKA can be activated without inducing cAMP flux or adenylyl cyclase activation. Deletion of the ubiquitously expressed regulatory subunit of PKA, R1a (Prkar1a), leads to constitutive activation of PKA. 33 Accordingly, MEFs from Prkar1a fl/fl mice were infected with lentiviruses expressing 4-OHTinducible CRE. 34 This resulted in acute loss of R1a with consequent PKA activation (as seen by increased levels of phospho-PKA substrates) and in a robust induction of Bim both at the mRNA and protein levels ( Figure 4a ). Induction of Bim triggered by R1a deletion resulted in a substantial reduction in the clonogenic survival of these MEFs. Remarkably, this could be prevented by the loss of Bim (Figure 4b ). This was also seen in short-term survival assay as well as when Prkar1a-deficient MEFs were treated with isoproterenol ( Figure 4c ).
c-Myc regulates BIM transcription during bAR stimulation. To identify the transcription factor(s) involved in bAR stimulation-mediated induction of Bim, we used the MEFs with 4-OHT-inducible PKACa expression (Figures 1a and 5a , inset). Transient transfection of these cells with a Bim promoter-luciferase reporter resulted in a robust induction of luciferase upon addition of 4-OHT. Using this assay, we mapped the Bim promoter and identified a conserved hexa-nucleotide region 140 bp upstream of the transcription start site, which was essential for PKA-mediated Bim upregulation ( Figure 5a ). This site potentially represents a non-canonical E-box capable of binding the proto-oncogene c-Myc, 35 and binding of Myc to this site could indeed be confirmed in electrophoretic mobility shift assays (EMSA) (Supplementary Figure S3e) . A critical role for c-Myc in Bim mRNA upregulation was first reported in the Em-Myc mouse pre-B/B lymphoma model. Bim mRNA and Bim protein levels were elevated in the apoptosis-prone B lymphoid cells of Em-MYC transgenic mice, and Bim-deficient Em-Myc mice had increased numbers of sIgM þ B cells. 36 However, a direct relationship between c-Myc and Bim transcription is yet to be established. Expression of c-Myc under 4-OHTregulation in MEFs resulted in a robust induction of Bim at both the mRNA and protein levels as, for example, seen in the luciferase assay ( Figure 5b ). This transcriptional induction of the Bim reporter construct could be abrogated either by mutating the conserved E-Box or by using the PKA inhibitor H-89 ( Figure 5b ). Furthermore, bAR stimulationtriggered induction of the Bim reporter in MEFs could also be abrogated by 10058-F4, 37 Whole genome chromatin immunoprecipitation (ChIP) and Next Generation Sequence analysis data generated as part of the ENCODE consortium by the Iyer lab (University of Texas, Austin) demonstrated that the Bim promoter was occupied by c-Myc in a variety of human cell lines (Figure 4e ; http://www. genome.ucsc.edu/cgi-bin/hgTracks?hgS_doOtherUser=sub-mit&hgS_otherUserName=Vishy&hgS_otherUserSession Name=bim_Myc). The c-Myc-binding region identified by ChIP spanned the sequence identified in the luciferase reporter assays corroborating our results (Figure 5e ). To validate and expand these findings, we generated a knock-in mouse strain in which the conserved c-Myc-binding sites within the Bim promoter were mutated (Supplementary Figure  S3a) . In MEFs derived from these mutant mice, Bim transcription was not upregulated upon enforced c-Myc expression or bAR activation (Figure 5f and Supplementary Figure S3b ). This demonstrates that c-Myc is essential for bAR-mediated Bim induction.
CBP is a required cofactor for c-Myc in Bim transcriptional induction. The data so far suggest that the transcription factor c-Myc is the critical driver of Bim transcriptional induction in response to cAMP/PKA stimulation. However, the link between PKA and c-Myc remains to be established. The only published report linking c-Myc directly with PKA is the transcriptional induction of the PKA catalytic subunit beta. 38 We first examined whether c- Figure S3c) . This mutation did, however, not have any discernable effect on the DNA-binding activity of c-Myc, as shown by EMSA and transcriptional activation of the Bim reporter construct or on the induction of Bim in MEFs when stably expressed, using 4-OHT-inducible lentiviral system (Supplementary Figures S3d-f) . The transcriptional activity of c-Myc can be augmented by the recruitment of the cofactor CBP. 39 We therefore tested whether such a process is critical for PKA-induced c-Myc transcriptional activity by RNAi-mediated knockdown of Cbp in MEFs. Interestingly, this resulted in the blockage of Bim induction, although both the WT and Cbp-knockdown cells were equally responsive to the bAR agonist, as reflected by CREB phosphorylation (Figure 6a) . Furthermore, induction of the Bim luciferase reporter was markedly impaired in Cbp-knockdown cells (Figure 6b) . Consequently, these cells were resistant to bAR agonist-induced apoptosis (Supplementary Figure S4a) . To prove that CBP regulates Bim expression through c-Myc, we used the Bim-luciferase reporter assay. Transfection of MEFs with CBP and the WT Bim promoter-luciferase construct resulted in a robust induction of this reporter in response to treatment with isoproterenol, whereas such induction was not seen with the reporter in which the c-Mycbinding site had been mutated (Figure 6c ).
Inactivating mutations in CBP are frequently found in acute lymphoblastic leukemia and in diffuse large cell B cell lymphomas. A large proportion of these mutations reside in the histone acetyltransferase (HAT) domain of CBP. 40 Moreover, epigenetic silencing of Bim is a feature in some types of B cell lymphoma. 41 We therefore examined whether HAT-deficient mutants of CBP were impaired in their ability to transcriptionally induce Bim. WT CBP could readily acetylate c-Myc in 293T cells but the HAT-deficient mutants H1451C or Y1234C 40 had lost this ability (Figure 6d ). Consistent with this, WT CBP could induce the Bim reporter, whereas the mutants failed to do so (Figure 6d ). These results were further corroborated in the human lung cancer-derived cell line LK-2, which does not have a functional CBP protein owing to a deletion of exon 3 of the Cbp gene. 42 bAR activation could readily induce Bim expression in the osteosarcoma cell line (143B) or B cell lymphoma cell line (Ramos), both of which have functional CBP, but not in CBP-deficient LK-2 cells (Supplementary Figure S4b) . However, introduction of WT Cbp could restore bAR stimulation-triggered Bim induction in these cells (Figure 6e and Supplementary Figures S4c and d) . These results demonstrate an essential role for CBP in c-Mycmediated Bim induction during bAR activation.
Epigenetic regulation of Bim during bAR signalling. The Bim gene is subject to epigenetic changes both by histone modification and by DNA methylation. In many cancers, such as multiple myeloma, treatment with histone deacetylase inhibitors increases Bim expression and triggers apoptosis in a manner that is dependent (at least in part) on Bim. 43 In chronic myeloid leukemia, changes in Bim promoter methylation status are associated with differences in Bim gene expression. 44 As CBP is a cofactor in c-Myc-regulated Bim expression, and CBP mutations in the HAT domain are associated with tumor development, 40 we investigated whether epigenetic changes in the Bim promoter occur during bAR signalling. Bisulphite sequence analysis of the Bim promoter from bAR responsive Ramos cells and the non-responsive LK-2 (CBP negative) cells showed a significant increase in CpG island methylation in the nonresponsive cells. This could be partially reversed by the ectopic expression of CBP from a lentiviral vector (Figure 7a) . Finally, ChIP analysis using MEFs expressing the catalytic subunit of PKA under 4-OHT regulation showed that both c-Myc and CBP bind constitutively to the Bim promoter, irrespective of the PKA activation status (Figure 7b ). This is consistent with the whole genome ChIP analysis (Figure 5e ), which showed that c-Myc could constitutively bind to the Bim promoter in different cell lines. However, histone 4 acetylation at the Bim promoter occurred specifically during PKA activation, corroborating the role of CBP in histone modification (Figure 7b last lane) . These results establish a role for CBP in the cAMP/PKA pathway in inducing epigenetic changes in the Bim gene.
Discussion
Increased sympathetic nervous activity in the myocardium is a classical feature of patients with HF. 18 Similarly, catecholamines, the primary transmitter of the sympathetic nervous system, regulate lymphocyte homeostasis by both autocrine and paracrine signalling. 4 In cardiac bAR signalling, it is well established that chronically increased stimulation and subsequent PKA activation could result in a robust apoptotic response. 6 Moreover, it was shown that the pro-apoptotic BH3-only protein Bim has a crucial role in cAMP-induced apoptosis in the T cell hybridoma line S49. 21 Therefore, our initial task was to explore the generality of this phenomenon in different tissues. We could demonstrate PKA activation and subsequent Bim induction both at the protein and mRNA levels by a variety of stimuli and in a variety of tissues (Figures 1 and 4) . We could also demonstrate that in thymic and heart tissues, Bim has a critical role in bARmediated apoptosis (Figure 2) . Our results also demonstrate that Bim has an important role in the heart development. In MEFs and thymocytes, there was a lag time between mRNA induction and protein accumulation. This could be partly due to the Bim protein stabilization by PKA, as we previously reported. 17 Lag time between transcript induction and protein accumulation has been reported in many previous studies, 45 particularly for the bAR pathway where feedback inhibition and receptor decoupling leads to receptor desensitization. Apart from protecting from bAR-induced cardiomyopathy, Bim À / À mice had a significantly larger heart (Supplementary Figure S2d) . This is not associated with hyperplasia rather because of increased size of cardiomyocytes, which does not change with isoproterenol treatment (Figures 3a and b) . As cardiac sympathetic nervous system is a strong regulator of cardiomyocyte size via bAR-dependent repression of proteolysis, 47 we believe that this size increase is a function of elevated bAR activity in the absence of Bim, similar to the observation in thymocytes. Furthermore, this hypertrophy is not associated with any pathology, as we could not detect any upregulation of pathology-associated genes such as Myh6 and 7; Serca2 or Col1a1 and Col3a1. 48 However, cardiac skeletal a-actin (Aska) was significantly increased in the KO tissue. On the basis of gene knock-out studies, it is believed that Aska contributes to muscular strength and contractility, 49 and thus our results suggest that blocking Bim expression in the heart will maintain the bAR-mediated inotropic function and only prevent the apoptotic arm of the signal transduction pathway.
The observation that deletion of Prkar1a results in Bimdependent apoptosis is significant in yet another context (Figure 4) . Inactivation of Prkar1a has been attributed to the development of cancer, such as multiple endocrinal neoplasia, myxoma and thyroid tumors. 50 Therefore, Prkar1a is believed to be a tumor suppressor. 50 However, our results suggest that cancer associated with Prkar1a mutations can develop only if there are cooperating oncogenic mutations that inhibit Bim-induced apoptosis. This could involve either genetic or epigenetic changes in the Bim gene or mutations that counter Bim induction, such as overexpression of antiapoptotic Bcl-2 family members. Given that Bim is a tumor suppressor in many cancers, 41, 51 it is possible that in those cancers where Prkar1a loss of heterozygosity causes elevated PKA activity, Bim is a critical tumor suppressor.
Our data show for the first time that c-Myc regulates the transcriptional induction of Bim during bAR activation. CREB is one of the main downstream targets of PKA and based on expression analysis, it was reported that Bim was a downstream target of CREB. 52 However, our results, obtained through a variety of methods, demonstrate that it is c-Myc that is mediating Bim transcriptional induction ( Figure 5 ). This finding is also relevant to Em-myc transgenic mice, a model of Burkitt's lymphoma, where deregulated c-Myc expression leads to increased Bim protein levels in B cells, 36 and thereby suppresses lymphoma development. However, c-Myc was Yet another significant finding in this study is the role of CBP in Bim induction. Our results demonstrated an absolute requirement of this transcriptional co-factor for bAR stimulation-triggered Bim induction ( Figure 6 ). Mutations in CBP are found in B cell lymphomas. 40 It is therefore possible that Bim downregulation in these cells may contribute to tumorigenesis, given that Bim functions as a tumour suppressor in B cell lymphoma. 36 Our results also show that although LK-2 cells have normal expression of p300, Bim can be upregulated only when CBP is forcibly expressed (Figure 6e and Supplementary Figures S4c and d) . This indicates that there is no functional redundancy between Cbp and p300 in inducing Bim transcription in spite of the extensive sequence similarity between these two proteins, in agreement with previous report. 53 Finally, our findings of epigenetic changes at the Bim locus (Figure 7 ), both in terms of histone acetylation and DNA methylation during PKA activation/CBP expression can be reconciled as CBP is a HAT and the interplay between these two processes in gene regulation has long been established. 54 On the basis of these findings, the following model (Figure 7c ) is proposed where bAR-mediated PKA activation leads to activation of CBP. The activated CBP leads to histone acetylation (and demethylation) at the Bim promoter locus, leading to increased gene expression.
Taken together, these results provide a clear link between cAMP/PKA pathway activation and Bim induction and consequent Bim-mediated apoptosis. Catecholamines are the prime mediators of cardiomyocyte apoptosis. 6 In the immune system, apart from the sympathetic nervous innervation of lymphoid organs, lymphocytes and macrophages themselves can be a source of catecholamines. 4, 24 This is known to contribute to thymocyte apoptosis and thymic involution can exert immune-modulatory effect as a prototypic stress response. 24 The present work is the first demonstration of the molecular pathway of bAR-mediated apoptosis. Understanding the molecular mechanism of this apoptotic pathway may provide critical clues for developing new drugs for the treatment of diseases associated with increased b-adrenergic activation.
Materials and Methods
Cell culture and luciferase assay. Cells were grown in DMEM supplemented with 10% foetal calf serum at 10% CO 2 and at 37 1C. Transient transfections were performed using Fugene (Roche, Indianapois, IN, USA). For PKACa or c-Myc-expressing cells, proteins expression was induced 24 h after transfection with 5 nm 4-OHT overnight, followed by luciferase assay using the Dual Luciferase (Promega, Alexandria, NSW, Australia) kit. For catecholamine induction, cells were treated 24 h after transfection, with isoproterenol (10 mM) and rolipram (10 mM) in serum-free medium overnight before the luciferase assay. . Production of lentiviral particles and infections were carried out as described. 17 Foetal thymic organ culture. Thymic organ culture was performed as described. 55 Thymus lobes obtained from E15 embryos were cultured in DMEM medium supplemented with 50 mM b-mercaptoethanol (Sigma, Castle Hill, NSW, Australia) plus 10% FCS. After 12 days, thymocytes were treated with 10 mM isoproterenol and 0.5 mM IBMX. Cells were isolated from these thymi for FACS, qPCR, western blot and cAMP analyses.
RT-quantitative PCR. Total RNA from thymocytes was isolated using TRIZOL. Complementary DNA (cDNA) was synthesized from 2 mg of total RNA using the Superscript III RT-PCR system (Catalogue number 18080-051 Invitrogen, Carlsbad, CA, USA), using oligo-dT primer, according to manufacturer's instructions. qPCR was carried out using Brilliant II SYBER Green QPCR master Mix (Catalogue number 600828 Stratagene, La Jolla, CA, USA). All cDNA samples were tested in triplicate using a Light cycler 480 Real-time PCR instrument (Roche). Following primers were used for qPCR reactions: Bim (F): Western and northern blot analyses. Western blot and northern blot analyses were performed as described before. 17 The following antibodies were used for western blot analyses: anti-Bim (3C5), anti-HA (6E2, Cell Signaling, Boston, MA, USA), anti-CBP, anti-p300 (N-15, Santa Cruz Biotechnology), anti pCREB Ser 133 , Affinity Bioreagents, Golden, CO, USA), anti HSP70, anti-acetyl lysine (9441, Cell Signaling), anti PRKAR1A (610609, BD Biosciences, CA, USA), anti-PKA substrate (9621, Cell Signaling), anti-PUMA (3043, ProSci, Poway, CA, USA). cAMP measurement. cAMP in cellular extracts was measured using cAMP Direct Immunoassay Kit (Cat# ab65355, Abcam, Cambridge, MA, USA).
Cardiomyocyte isolation. Cardiomyocytes were isolated by Langendorff perfusion technique, as described. 56 In vitro PKA kinase assay. In vitro PKA kinase assay was performed as described. 17 Catecholamine measurements. Blood samples were collected from anesthetized animals by cardiac puncture. Plasma were prepared by centrifugation and stored at À 80 1C, until assay with high-performance liquid chromatography (HPLC). 57 This method allowed simultaneous determination of norepinephrine and epinephrine. Catecholamines were adsorbed with activated alumina, separated by HPLC, and quantified by electrochemical detection.
Histology. Hearts were fixed in 10% formalin in phosphate-buffered saline, paraffin-embedded, serially sectioned (5 mM) and stained with Picrosirius red or Masson's trichrome. 58 Echocardiography. Animals were anesthetized by isoflurane. Using an IE33 ultrasound system and a linear 15 MHz probe, two-dimentional (2D) short-axis loop of the LV was acquired for measurement of LV cross-sectional areas at the diastole and systole. LV fractional shortening was calculated from LV diameters at the diastole and systole from the M-mode traces derived from 2D image, as described before. 58 Promoter methylation analysis. Promoter methylation was analysed by bisulphite sequencing of the BIM promoter using MethylDetector kit (Active Motif, Carlsbad, CA, USA). Sulphonated DNA samples (from Ramos, LK-2 and LK-2 cells expressing functional CBP) were amplified by PCR using primers specific for CpG island corresponding to bases À 1513 to À 948 (relative to the transcription start site on human BIM gene). PCR-amplified fragments were cloned into PCRII-TOPO vector using TOPO TA Cloning kit (Life Technologies, Grand Island, NY, USA). Ten clones from each cloning were sequenced and analysed using BISMA software (Jacobs University Breman, Germany).
